semaglutide subcutaneous injection side effects Day 2: Wegovy (Semaglutide 2.4 mg weekly injection) Class: GLP-1 receptor agonist Avg Weight Loss: ~15% of baseline weight Dosing: Weekly FDA Approved: June 2021 for chronic weight management Pros ๐๐๐ง ๐๐๐ข๐ ๐ก๐ญ-๐๐จ๐ฌ๐ฌ ๐๐ง๐ฃ๐๐๐ญ๐ข๐จ๐ง๐ฌ ๐๐๐๐๐๐ญ ๐๐จ๐ฎ๐ซ
Pay in 4 interest-free payments of $5.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Jul 31 - Aug 5



























